Sri Lanka Medical Association of North America
  • off canvas menu mobile
    • HOME
    • MEMBERS
      • Why join SLMANA
      • Join/ Renew Membership
      • Executive Committee
      • Downloadable forms
    • MISSION
    • EVENTS
    • EDUCATION
      • CME Archives
        • 2017
        • 2015
        • 2013
        • 2011
          • 2011 Poster Abstracts
        • 2009
          • 2009 CME Program Agenda
          • 2009 Welcome Remarks
          • 2009 Poster Abstracts
        • 2007
    • PROJECTS
      • 2021-2022
      • 2019-2020
      • 2017 – 2019
      • 2015 – 2016
      • 2010 – 2011
    • NEWSLETTER
      • 2018 June
        • Pediatric Endocrinology
      • 2018 – February
        • Type 1 Diabetes in Sri Lanka: An Overview
        • Kidney Failure in the Villages of Sri Lanka
        • New Paradigm for Treatment of Type 2 Diabetes
        • T2DM and CVD
        • Editor’s Message – February 2018
      • 2017 – June
        • 12TH ANNUAL EAST-COAST CRICKET FESTIVAL
        • SLMANA CHARITY BALL
        • Colonel Henry Steel Olcott
        • How a Drooping Eyelid Can Affect Your Sleep
        • Pediatric Obesity Treatment and Prevention Guidelines
        • Recent Publications from SLMANA Members
      • 2017 – January
        • President’s Message
        • Editors message Ramona and Rushika
        • Alzheimer’s in the News in Sri Lanka, “Brain Bank” at Sri Jayawardenepura University
        • Improving the Quality of Care for Acute and Critically Ill Patients in Sri Lanka: National Intensive Care Surveillance (NICS)
        • Crohn’s and Colitis: Stony Brook Walks for a Cure
        • Dengue Fever: Sri Lanka Fights Back
        • FDA Approves Use of the Artificial Pancreas
        • The Human Microbiome and Fecal Microbial Transplantation
        • Macra Who!
    • CONTACT US
    • DONATE NOW
Sri Lanka Medical Association of North America
  • HOME
  • MEMBERS
    • Why join SLMANA
    • Join/ Renew Membership
    • Executive Committee
    • Downloadable forms
  • MISSION
  • EVENTS
  • EDUCATION
    • CME Archives
      • 2017
      • 2015
      • 2013
      • 2011
        • 2011 Poster Abstracts
      • 2009
        • 2009 CME Program Agenda
        • 2009 Welcome Remarks
        • 2009 Poster Abstracts
      • 2007
  • PROJECTS
    • 2021 – 2022
    • 2019 – 2020
    • 2017 – 2019
    • 2015 – 2016
    • 2010 – 2011
  • NEWSLETTER
    • 2019 July
      • Editor’s message
      • Central Park Birding Outing April 2019
      • Newsletter – July 2019
    • 2019 – January
      • Editor’s Message – Happy new year – 2019
      • Help Them Walk Again
      • Member Talent Show: Sponsor Darshi Sunderam, MD
      • Outgoing President’s Message – 2017-2018
      • Incoming President’s Message – 2019
    • 2018 – June
      • Flooding and Rain in Sri Lanka
      • Reducing Plastic Use in Sri Lanka
      • Medical News
      • Pediatric Endocrinology
    • 2018 – February
      • Editor’s Message – February 2018
      • Upcoming Events
      • Type 1 Diabetes in Sri Lanka: An Overview
      • Update on Treatment of Type 1 Diabetes: The Artificial Pancreas
      • Kidney Failure in the Villages of Sri Lanka
      • New Paradigm for Treatment of Type 2 Diabetes
      • Dementia
      • T2DM and CVD
    • 2017 – June
      • 12TH ANNUAL EAST-COAST CRICKET FESTIVAL
      • SLMANA CHARITY BALL
      • Colonel Henry Steel Olcott
      • How a Drooping Eyelid Can Affect Your Sleep
      • Pediatric Obesity Treatment and Prevention Guidelines
      • Recent Publications from SLMANA Members
    • 2017 – January
      • President’s Message
      • Editors message Ramona and Rushika
      • Alzheimer’s in the News in Sri Lanka
      • Improving the Quality of Care for Acute and Critically Ill Patients in Sri Lanka
      • Crohn’s and Colitis: Stony Brook Walks for a Cure
      • Dengue Fever: Sri Lanka Fights Back
      • FDA Approves Use of the Artificial Pancreas
      • The Human Microbiome and Fecal Microbial Transplantation
      • Macra Who!
  • MEMBERS’S RESEARCH
    • Cardiovascular disease
      • Lipid QI Presentation deck
    • Gastroenterology
      • Bowel Disease Treatment Plans
    • Orthopedics
      • Rotator Cuff Repair
      • CTR
      • TTP MSSNY poster
  • CONTACT US
Newsletter

FDA Approves Use of the Artificial Pancreas

January 21, 2017
By admin
0 Comment
545 Views

In September 2016, the first closed loop insulin delivery system, also known as the “artificial pancreas”, was approved by the FDA for use in patients with type 1 diabetes. Medtronic’s Minimed 670G is a two device insulin delivery and glucose monitoring system that continuously delivers insulin and checks blood sugars every 5 minutes. Through an algorithm and real time data, the pump can adjust rates of basal insulin delivery to keep blood sugars within the target range. Patients will still need to input carbohydrate information for bolus insulin delivery to cover the food they eat. FDA approval came after a study, funded by the Juvenile Diabetes Research Foundation, assessed the impact of the closed loop system on Hemogloblin A1C and glucose variability over a 3 month time period. The study reported a decreasee in A1C from a mean of 7.4 (SD 0.9)% to 6.9 (SD 0.6)% with the percent of glucose values within target range increasing from 66.7% to 72.2% during that time. The number of hypoglycemic and hyperglycemic events experienced during the day and overnight improved over the time period as well (JAMA 316(13):1407-1408).

Type 1 diabetes is a chronic disease that affects over 1.25 million adults and children within the United States alone. Management of this lifelong illness includes frequent blood sugar checks and insulin administration, monitoring of food intake and adjustment of insulin doses for illness, menses, stress and activity. The risk of long-term microvascular and macrovascular complications, such as nephropathy, retinopathy, neuropathy and cardiovascular disease, increases with poor glycemic control. In the past, fixed injections of insulin with fixed meal times and carbohydrate quantities served as the treatment plan. Over the years this was replaced by multiple daily injections of insulin to allow for more freedom with respect to eating behaviors, followed by insulin pump therapy, which delivers insulin through a cannula that is inserted under the skin. The addition of the continuous glucose monitor has allowed us to assess the minute to minute variations in blood sugar, which has led to improvements in glycemic control as well as quality of life for patients and their caregivers.

The Minimed 670G is approved for use in adults and children 14 years of age and older. Studies are currently underway assessing the safety and efficacy of its use in children with type 1 diabetes between the ages of 7 and 13 years. The 670G is due to be available to patients in the spring of 2017.

– Rushika Conroy, MD


Previous Story
Dengue Fever: Sri Lanka Fights Back
Next Story
The Human Microbiome and Fecal Microbial Transplantation

Recent Post

  • SLMANA represented at BLM protest march to Wasgington Sq, NY, June 6th 2020 Monday, 8, Jun
  • Central Park Birding Outing April 2019 Saturday, 18, Jan
  • Editor’s message Saturday, 18, Jan
  • Outgoing President’s Message – 2017-2018 Friday, 1, Nov
  • Incoming President’s Message – 2019 Friday, 1, Nov

Recent Comments

    Tags

    Charity

    SLMANA

    sri lanka medical association of North America

    Follow us

    Downloadable Forms

    Click here to download

    Useful External Links

    • – Information on Dengue fever
    • – Information on Orthopaedic injuries
    • – Stop Sports Injuries
    • – Gamage and Jayawardana BMC Public Health (2018) 18:64DOI 10.1186/s12889-017-4622-z
    SLMANA Inc.™ © 2021 SLMANA Inc. All Rights Reserved.
    Terms of use I Privacy Policy
    Developed by amwebbers.com
    SearchPostsLoginCart
    Monday, 8, Jun
    SLMANA represented at BLM protest march to Wasgington Sq, NY, June 6th 2020
    Saturday, 18, Jan
    Central Park Birding Outing April 2019
    Saturday, 18, Jan
    Editor’s message
    Friday, 1, Nov
    Outgoing President’s Message – 2017-2018
    Friday, 1, Nov
    Incoming President’s Message – 2019
    Friday, 1, Nov
    Editor’s Message

    Welcome back,